| |
|
|
|
|
Richard Girling
|
|
Partner
|
|
Richard Girling joins Centerview Partners from Merrill Lynch in London where he established that firm’s European healthcare practice in 1998, and was Global Co-Head of Healthcare investment banking for the last six of those years.
Following the acquisition by Bank of America, he was appointed the head of the merged Europe, Middle East and Asia (EMEA) and Asia-Pacific healthcare practices for the combined organization.
Mr. Girling has advised on many of the largest healthcare transactions in Europe and Asia including: Sanofi-Synthelabo's $73 billion acquisition of Aventis, the $24 billion LBO of Alliance Boots plc, AstraZeneca in its $15 billion acquisition of MedImmune, Mayne Pharma's $2 billion sale to Hospira, Alliance Unichem in its $12 billion merger with Boots, CSL in its acquisition of Aventis Behring, and numerous transactions for Roche.
Mr. Girling joined Merrill Lynch in 1998 from Salomon Brothers, where he worked from 1989 to 1998 and was head of the European Pharmaceutical and Healthcare team.
Mr. Girling holds a B.A. and M.A. degrees in Biochemistry from Oxford University.
|
|
|
|
|